ConvaTec Group PLC (CNVVY)
13.02
+0.84
(+6.93%)
USD |
OTCM |
May 03, 15:45
ConvaTec Group Market Cap: 6.671B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 6.239B |
| May 01, 2024 | 6.380B |
| April 30, 2024 | 6.652B |
| April 29, 2024 | 6.471B |
| April 26, 2024 | 6.652B |
| April 25, 2024 | 6.969B |
| April 24, 2024 | 7.363B |
| April 23, 2024 | 7.320B |
| April 22, 2024 | 7.197B |
| April 19, 2024 | 7.282B |
| April 18, 2024 | 7.238B |
| April 17, 2024 | 7.213B |
| April 16, 2024 | 7.213B |
| April 15, 2024 | 7.277B |
| April 12, 2024 | 7.277B |
| April 11, 2024 | 7.348B |
| April 10, 2024 | 7.246B |
| April 09, 2024 | 7.226B |
| April 08, 2024 | 7.226B |
| April 05, 2024 | 7.448B |
| April 04, 2024 | 7.566B |
| April 03, 2024 | 7.733B |
| April 02, 2024 | 7.687B |
| April 01, 2024 | 7.569B |
| March 28, 2024 | 7.543B |
| Date | Value |
|---|---|
| March 27, 2024 | 7.543B |
| March 26, 2024 | 7.661B |
| March 25, 2024 | 7.466B |
| March 22, 2024 | 7.466B |
| March 21, 2024 | 7.584B |
| March 20, 2024 | 7.584B |
| March 19, 2024 | 7.584B |
| March 18, 2024 | 7.261B |
| March 15, 2024 | 7.261B |
| March 14, 2024 | 7.261B |
| March 13, 2024 | 7.261B |
| March 12, 2024 | 7.194B |
| March 11, 2024 | 7.194B |
| March 08, 2024 | 7.194B |
| March 07, 2024 | 7.194B |
| March 06, 2024 | 6.390B |
| March 05, 2024 | 6.390B |
| March 04, 2024 | 6.390B |
| March 01, 2024 | 6.390B |
| February 29, 2024 | 6.349B |
| February 28, 2024 | 6.349B |
| February 27, 2024 | 6.349B |
| February 26, 2024 | 6.349B |
| February 23, 2024 | 6.349B |
| February 22, 2024 | 6.349B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.327B
Minimum
Mar 18 2020
7.733B
Maximum
Apr 03 2024
5.405B
Average
5.446B
Median
Jun 22 2023
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 294.96M |
| Biodexa Pharmaceuticals Plc | 5.218M |
| Verona Pharma PLC | 1.269B |
| NuCana PLC | 8.458M |
| Autolus Therapeutics PLC | 1.113B |
Market Cap Related Metrics
| PE Ratio | 51.66 |
| PS Ratio | 3.118 |
| PEG Ratio | 5.992 |
| Price to Book Value | 3.941 |
| Price to Free Cash Flow | 28.04 |
| Price | 13.02 |
| Earnings Yield | 1.94% |
| PEGY Ratio | 4.854 |
| Operating PE Ratio | 25.19 |
| Normalized PE Ratio | 44.25 |